Epicriptine
Main article: Dihydroergocryptine
![]()  | |
| Clinical data | |
|---|---|
| Pregnancy category  | 
  | 
| Routes of administration  | Oral | 
| ATC code | N04BC03 (WHO) (alpha/beta) | 
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
  | |
| Synonyms | beta-Dihydroergocryptine | 
| CAS Number | 19467-62-0 | 
| PubChem (CID) | 3084313 | 
| ChemSpider | 2341400 | 
| UNII | 5M64643B5U | 
| ChEBI | CHEBI:59925 | 
| ChEMBL | CHEMBL1378681 | 
| ECHA InfoCard | 100.039.157 | 
| Chemical and physical data | |
| Formula | C32H43N5O5 | 
| Molar mass | 577.715 g/mol | 
| 3D model (Jmol) | Interactive image | 
  | |
  | |
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.[1]
References
This article is issued from Wikipedia - version of the 12/16/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
